One potential reason for the negative correlation between dosing and a robust anti-tumour CD8+ T cell response is that hyper-activation of STING can drive apotosis of T and B cells, inhibiting the development of tumour-specific adaptive immune responses [94]. Here, CD8A is linked to neoplasm.